n 0 Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China Title: The clinical characteristics of 2019 novel coronavirus severe pneumonia *Corresponding Author
n 1 Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
n 2 China through a drug-target interaction deep learning model
n 3 Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China
n 4 Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm
n 5 Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage
n 6 MERS-CoV spillover at the camel-human interface
n 7 Identification of a super-spreading chain of transmission associated with COVID-19
n 8 Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
n 9 Clinical Characteristics of Two Human to Human Transmitted Coronaviruses: Corona Virus Disease 2019 versus Middle East Respiratory Syndrome Coronavirus
n 10 Alpha-ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication Structure-based design, synthesis, and activity assessment
n 11 Awareness of MERS-CoV among Staff Members of Prince Sultan Military Medical City in Riyadh, Saudi Arabia
n 12 Gender differences in patients with COVID-19: Focus on severity and mortality
n 13 Evolution and variation of 2019-novel coronavirus
n 14 SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability
n 15 Potential Factors for Prediction of Disease Severity of COVID-19 Patients
n 16 Teicoplanin potently blocks the cell entry of 2019-nCoV
n 17 Bat-man disease transmission: zoonotic pathogens from wildlife reservoirs to human populations
n 18 A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm
n 19 Host Determinants of MERS-CoV Transmission and Pathogenesis
n 20 Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia
n 21 Tissue tropism and transmission ecology predict virulence of human RNA viruses
n 22 Adaptive evolution of bat dipeptidyl peptidase 4 (dpp4): implications for the origin and emergence of Middle East respiratory syndrome coronavirus
n 23 Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases
n 24 Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis
n 25 Knowledge and attitude of healthcare workers about middle east respiratory syndrome in multispecialty hospitals of Qassim, Saudi Arabia
n 26 Molecular epidemiology and characterization of human coronavirus
n 27 Perception and Attitude of Emergency Room Resident Physicians toward Middle East Respiratory Syndrome Outbreak
n 28 MERS coronavirus: diagnostics, epidemiology and transmission
n 29 Coronaviruses: emerging and re-emerging pathogens in humans and animals
n 30 Replication of MERS and SARS coronaviruses in bat cells offers insights to their ancestral origins
e 0 1
e 2 1
e 3 1
e 4 1
e 5 1
e 6 2
e 7 2
e 8 2
e 9 1
e 10 1
e 11 1
e 12 3
e 13 3
e 14 3
e 15 3
e 16 1
e 17 11
e 18 1
e 19 1
e 20 1
e 21 1
e 22 15
e 23 1
e 24 1
e 25 1
e 26 1
e 27 18
e 28 1
e 29 1
e 30 29